Summary. The possible role of platelet-activating factor (PAF) in the uterine responses associated with implantation was investigated. Attempts to trigger a decidual cell response in the uteri of hormonally sensitized, ovariectomized mice by instilling PAF\x=req-\ acether (1\p=n-\1000ng) intraluminally were unsuccessful. The effect of PAF antagonists on implantation was investigated in females ovariectomized on Day 3 of pregnancy and treated with progesterone. Implantation was induced in these females by injection of 10 ng oestradiol-17\g=b\ on Day 8. Hourly intraperitoneal injections of three PAF antagonists (WEB 2086, CV 3988 and BN 52021 at doses of 1\ m=. \ 2\ p=n-\ 1\ m=. \ 4 mg/kg) given over a 24-h period starting 1 h before the injection of oestradiol-17\g=b\ had no significant effect on the occurrence of implantation sites. Intraluminal injection of WEB 2086 (15 \g=m\g) or BN 52021 (5 pg) either 3 h before or 6 h after the nidatory oestradiol also had no significant inhibitory effect on implantation. given once daily over the first 4 days of pregnancy at a dose of 40 \g=m\g/30g body weight had no inhibitory effect on the establishment of pregnancy. These results are not consistent with a critical role for PAF in implantation in mice.
Introduction
There are still many unsolved problems concerning the various signals and mediators that may be involved in controlling implantation and the associated uterine responses. One suggestion that has arisen in recent years is that platelet-activating factor (PAF) may represent one important signal between the embryo and maternal tissues. This idea stems from the work of O'Neill (1985a) who reported a transient decrease in maternal platelet numbers in the Quackenbush strain of mice in the early stages of pregnancy. It has also been reported that mouse and human embryos produce a platelet-activating factor indistinguishable from those of the well characterized platelet-activating factor PAF-acether ( 1 -o-alkyl-2-acetyl-5«-glycero-3-phosphocholine) (O'Neill, 1985b; Collier et ai, 1988) . The idea that PAF might be physiologically important in early pregnancy gained further support from the observation that the production of embryo-derived PAF by human embryos correlated with the potential of embryos produced by in-vitro fertilization procedures (O'Neill et ai, 1987) . In addition, Spinks & O'Neill (1987, 1988) reported that the administration of inhibitors of platelet activation to mice during early pregnancy inhibited implan¬ tation. Acker et ai (1988a) suggested that another PAF antagonist (BN 52021) could inhibit implantation in rats. In addition to PAF from embryonic sources, the uterus of both the rat (Yasuda et ai, 1986 ) and rabbit (Angle et ai, 1988 ) also may produce PAF. The role(s) that embryo-derived or uterine PAF may play in early pregnancy is (are) uncertain. Embryo-derived PAF would appear to be one of the earliest potential signals for the maternal recognition of pregnancy. PAF may also affect the metabolism of preimplantation embryos (O'Neill, 1987) . In addition, in view of its known, potent effects on vascular permeability and vasodilatation and effects on a variety of cell types (Braquet et ai, 1987) , a role for PAF at implan¬ tation sites could be envisaged (Adamson et ai, 1987) . Increased vascular permeability is one of the earliest obvious uterine responses to an implanting blastocyst (Psychoyos, 1973) , preceding decidual transformation of the neighbouring stromal cells (Finn & McLaren, 1967) . Acker et ai (1988b) reported that intrauterine administration of PAF in rats could induce decidualization and Angle et ai (1988) (Milligan & Finn, 1988 ) at doses of 1 -4, 1 -3, 1 -2 and 1-3 mg/kg respectively. Control mice received injections of saline or 0-5% DMSO in saline, as appropriate. Experiment 1. In the initial experiments the possibility that PAF-acether might be an effective deciduogenic stimulus was investigated. Ovariectomized mice were treated with 100 ng oestradiol-17ß for 3 days, followed by 2 days of no treatment and then 3 days of progesterone ( 1 mg) and oestradiol-17ß ( 10 ng): this produces maximal sensitivity to a decidual stimulus on the 3rd day of combined progesterone and oestradiol treatment (Finn & Martin, 1972) . Intraluminal instillation (5-20 µ ) of PAF-acether, vehicle or oil into one or both uterine horns was performed using ether anaesthesia. Instillations were made via a 25-gauge needle at the anterior tip of the uterine horn. Daily treatment with 1 mg progesterone continued until the animals were killed for assessment of the uterine decidual cell response by uterine weight and histological examination.
Experiment 2. The failure to demonstrate any decidi°^e nic effect of PAF-acether in Exp. 1 led to an investigation of the effect of PAF-acether on uterine vascular permeability. Ovariectomized mice were treated with lOOng oestradiol-17ß for 3 days, followed by 2 days of no treatment and then 3 days of progesterone (1 mg). On the 3rd day of progesterone treatment, 5 µ PAF-acether, saline or arachis oil were instilled into one uterine horn. Uterine vascular permeability was assessed 6 h later by determining the accumulation of radiolabelled albumin 30 min after the injection of 0-5 µ 125I-labelled human serum albumin (Arvidson, 1977; Milligan & Mirembe, 1985 (Psychoyos, 1961) 
Results
The effectiveness of the PAF-acether used in this series of experiments was confirmed by three different methods. Subplantar administration of PAF is known to induce rat paw oedema (Goldenberg & Meurer, 1984) ; in the present study, 4 rats were given a subplantar injection of 2 pg PAF-acether and all exhibited a marked paw oedema within 60 min. This effect was not seen after injection of the vehicle. In mice, the intravenous injection of PAF will induce death by bronchoconstriction and cardiovascular effects (Myers et ai, 1983; Criscuoli & Subissi, 1987) . This was confirmed in the present study when 90 pg PAF-acether/kg injected i.v. in 01 ml caused death within 30 min of 9/10 mice. Finally, the i.p. injection of 2 pg PAF-acether into 4 splenectomized mice caused a 15% decrease in platelet numbers within 60 min.
The effectiveness of the PAF antagonists was tested by assessing their ability to block the lethal effect of i.v. administered PAF. Female mice received two i.p. injections of the antagonists 1 h apart and were then injected i.v. with 90 pg PAF-acether/kg. In the absence of any inhibitor, only 3/12 (25%) animals were still surviving 30 min after PAF-acether administration. Pretreatment with the PAF antagonists at the doses used in subsequent experiments significantly improved the survival rate, with the numbers surviving after WEB 2086, BN 52021, CV 3988 and SRI 63-441 being 6/6 (100%), 8/12 (67%), 9/12 (75%) and 8/8 (100%), respectively. Experiment 1: the deciduogenic potential of PAF-acether in ovariectomized, steroid-treated mice PAF-acether was injected intraluminally under a variety of conditions (Table 1) . While the instillation of arachis oil produced massive decidual responses along the length of the instilled horn, the instillation of PAF-acether was ineffective regardless of the dose (Exps la and lb). The only signs of decidualization in the horns instilled with PAF were occasionally at the site of instillation. The larger uterine weights in Exp. 1(b) can be explained by the increased age of these animals. The possibility that the negative response to PAF-acether was the result of rapid loss of the instilled material from the cervical end of the horn was tested in Exp. 1(c) by ligating the uterus at the time of instillation but no decidual response was observed. 'Values significantly different from corresponding con¬ trol horns: *P < 002, **P < 001. 10-6 ± 1-2 101 ± 11 10-7 ± 10 9-8 ± 1-7
Experiment 5: effect of SRI 63-441 in early pregnancy There was no significant difference between the females treated with SRI 63-441 or PBS in the number of pregnancies (9/10 in both treatments), or the number of implantation sites per pregnant female (mean + s.e.m. 10-8 + 0-84, and 120 ± 0-78, respectively).
Discussion
Many of the established biochemical and biological properties of PAF would be consistent with a role for this compound as a mediator of uterine responses associated with implantation. In other situations, PAF has been implicated in many aspects of inflammation including the activation of platelets and leucocytes and the liberation of vasoactive substances such as prostaglandins. Since the response of the uterus to an implanting blastocyst appears to resemble an inflammatory-like reaction (Finn, 1977) and is characterized by an increase in vascular permeability (Psychoyos, 1961) , some involvement of PAF would not be unexpected.
The results from the present study, however, do not provide any evidence to support the proposal that PAF has either a critical or a principal role in either the induction of decidualization or the process of implantation. Even at very high doses, the intraluminal administration of Table 4 . Effect of intraluminal instillation of (5µ1) PAF antagonists, given 6 h before, or 3 h after, the nidatory injection of lOng oestradiol-17ß, on delayed implantation in mice (Exp. Values significantly different from those for non-instilled horns: *P < 005, **P < 001.
4)
PAF-acether failed to induce decidualization in appropriately sensitized females, and had little effect on uterine vascular permeability. This failure of PAF-acether to induce decidualization is in contrast to the report of Acker et ai (1988b) that the compound (in doses of 250-1000 ng) would induce decidualization in pseudopregnant rats and that this effect could be blocked by the PAF antagonist BN 52021. A number of explanations might account for this discrepancy. Several stud¬ ies have suggested that rats are much more sensitive to the decidualizing effect of intraluminal stimuli and the instillation of even non-specific stimuli (e.g. physiological saline) can induce deci¬ dual responses (Finn & Keen, 1963) ; in contrast, mice are relatively insensitive to the effects of such procedures (Finn, 1965) . Such a species difference may be coupled with the fact that PAF may be inactivated rapidly (Braquet et ai, 1987) (1987, 1988) reported that inhibitors of platelet activation given i.p. in early pregnancy caused up to a 50% decrease in the numbers of implantation sites. The protocol used by these authors, however, differed from the present investigation both in the frequency of the administration of the inhibitors and the period over which they were given, as well as in the nature of the inhibitors. In particular, Spinks & O'Neill (1987 
